SCHEMBL31468458

SCHEMBL31468458

C=Cc1ccccc1[Si](CCCN(CC)CC)(OCC)OCC

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.34
ALDH1A1 P00352 1/20 0.33
CHRM1 P11229 2/20 0.33
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
ADRA1A P35348 2/20 0.33
OPRM1 P35372 2/20 0.33
DRD3 P35462 2/20 0.33
SLC6A3 Q01959 2/20 0.33
KCNH2 Q12809 2/20 0.33
CHRM2 P08172 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
DRD1 P21728 1/20 0.33
DRD2 P14416 1/20 0.32
ADRA2C P18825 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HRH1 P35367 1/20 0.32
OPRK1 P41145 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31468551 0.91 HTR1B (0.33) OPRM1DRD3DRD2OPRK1BCHE
SCHEMBL31468555 0.88 ALDH1A1 (0.37) SIGMAR1ALDH1A1CHRM1SLC6A2SLC6A4
SCHEMBL31468618 0.88 KDM4E (0.33) SIGMAR1ALDH1A1HTR2AHRH1
SCHEMBL31468621 0.83 ALDH1A1 (0.30) ALDH1A1
SCHEMBL31468597 0.82 HTR1B (0.34) DRD3DRD2BCHEACHE
SCHEMBL31468579 0.81 SIGMAR1 (0.37) SIGMAR1ALDH1A1CHRM1SLC6A2SLC6A4
SCHEMBL31468526 0.79 HTR1B (0.34) OPRM1DRD3KCNH2DRD2OPRK1
SCHEMBL27769595 0.78 ALDH1A1 (0.34) ALDH1A1
SCHEMBL31468626 0.76 ALDH1A1 (0.31) ALDH1A1
SCHEMBL31468598 0.76 MAOA (0.32) ALDH1A1KCNH2SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4541800-A1 NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME Shin-Etsu Chemical Co., Ltd. (JP) 2025-04-23 EP disclosed
US-20250122230-A1 NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122230-A1 NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME HRH3, HRH4, OR10J3 SIGMAR1 176/4885ALDH1A1 3683/4885CHRM1 307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.